摘要
目的分析针对习惯性流产患者,阿司匹林联合低分子肝素的治疗效果。方法选取2017年2月至2019年6月在本院接受治疗的习惯性流产患者100例作为研究对象,依照随机分配的方式分为实验组与对照组,每组50例。对照组患者采用阿司匹林开展治疗,实验组患者采用阿司匹林联合低分子肝素开展治疗,治疗后,对比两组患者流产率、足月产率、活产率、不良反应发生率以及分娩孕周。结果实验组足月产率以及活产率分别为76.0%与96.0%,高于对照组的54.0%与84.0%,差异有统计学意义(P<0.05);实验组分娩孕周时长为(39.14±2.01)周长于对照组的(37.25±1.04)周,差异有统计学意义(P<0.05);实验组不良反应发生率为6.0%,低于对照组的20.0%,差异有统计学意义(P<0.05)。结论阿司匹林联合低分子肝素治疗效果显著,具有临床推广价值。
Objective To analyze the treatment effect of aspirin and low molecular weight heparin on habitual abortion patients.Methods 100 cases patients with habitual abortion from February 2017 to June 2019 who came to our hospital for treatment were selected as the study subjects.According to the way of random distribution,the patients were divided into experimental group and control group,with 50 cases in each group.The control group was used Aspirin to treat the patients,the experimental group was used aspirin combined with low molecular weight heparin to treat the patients.After the treatment,the abortion rate,full-term rate,live birth rate and pregnancy week of delivery were compared between the two groups.Results The full-term rate and live rate of the experimental group were 76.0%and 96.0%,respectively,which were higher than that of the control group(54.0%and 84.0%),and the data difference between the groups was significant(P<0.05).The gestational age of the experimental group was(39.14±2.01)weeks,which was longer than that of the control group(37.25±1.04)weeks,and the difference between the two groups was significant(P<0.05).The adverse reaction rate of the experimental group was 6.0%,which was lower than that of the control group(20.0%),and the difference between the two groups was significant(P<0.05).Conclusion Aspirin combined with low-molecular-weight heparin is more effective and has clinical promotion value.
作者
邱文芳
温泉
刘素梅
Qiu Wenfang;Wen Quan;Liu Sumei(Department of Gynecology,Ganzhou Maternal and Child Health Hospital,Ganzhou,Jiangxi,341000,China)
出处
《当代医学》
2020年第32期20-22,共3页
Contemporary Medicine
关键词
阿司匹林
低分子肝素
习惯性流产
临床疗效
Aspirin
Low molecular weight heparin
Habitual abortion
Clinical efficacy
